TP53 and gastric cancer: In vitro, it was demonstrated that RPL11 increases the sensitivity of GC cell lines to 5-FU by activating the p53 pathway suggesting the potential role of increased level of RPL11 in combination with 5-FU in the efficient treatment of GC [120].